Government regulation is needed to prevent biased under-reporting of clinical trials [6]

British Medical Journal

Volumn 329, Issue 7463, 2004, Pages 462-

  Chalmers, Iain ^a  

^a James Lind Library   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; GOVERNMENT REGULATION; HEALTH CARE; HEALTH CARE POLICY; LETTER; PRIORITY JOURNAL; PUBLISHING;

BIAS (EPIDEMIOLOGY); DRUG INDUSTRY; GREAT BRITAIN; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 4344663518     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Sykes R. Being a modern pharmaceutical company. BMJ 1998;317:1172-80.
2. Gibson L. GlaxoSmithKline to publish clinical trials after US lawsuit. BMJ 2004;328:1513.
3. Chalmers I. In the dark. New Scientist 2004 March 6:9.